The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions

被引:5
|
作者
Habal, Petr [1 ,2 ]
Jankovicova, Karolina [2 ,3 ]
Omran, Nedal [1 ,2 ]
Kondelkova, Katerina [2 ,3 ]
Krejsek, Jan [2 ,3 ]
Mandak, Jiri [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med Hradec Kralove, Dept Cardiac Surg, Prague, Czech Republic
[2] Univ Hosp, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med Hradec Kralove, Dept Clin Immunol & Allergy, Prague, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2013年 / 157卷 / 04期
关键词
malignant pleural effusion; thoracoscopy; talc; sCD-163; sTLR-2; TOLL-LIKE RECEPTORS; EXPRESSION; PLEURODESIS; SURVIVAL; PATHOPHYSIOLOGY; MECHANISMS; CYTOKINES; IMMUNITY; POUDRAGE; FLUID;
D O I
10.5507/bp.2012.095
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and palliative. Among others, chemical pleurodesis using talc can be performed in selected patients. Talc is hydrated magnesium silicate (chemically H2Mg3 (SiO3)(4)) and has been used for pleurodesis since 1935. Videothoracoscopic talc powder insufflation (talc poudrage) is the most effective. However, markers of inflammatory reactions to extraneous substances like talc are not fully understood. The aim of this study was to assess the course of local inflammatory changes in the pleural cavity after talc insufflation. Methods. The Department of Cardiac Surgery of the Faculty of Medicine and University Hospital in Hradec Kralove, treated 47 patients aged 65 on average; 29 males and 18 females with proven recurrent malignant pleural effusion of various aetiologies from January 2009 to December 2010. They were retrospectively divided into group A (40 patients) without recurring effusion, and group B (7 patients) with recurring effusion and the need for thoracentesis or chest drainage during the 9-month monitoring. Results. Major findings were made in soluble forms of cell receptors. Group B showed statistically higher levels of the anti-inflammatory form of sCD-163 receptor in pleural fluid before the talc poudrage. This showed limited ability to create an adequate inflammatory response to external stimuli. This group also showed lower levels of the inflammatory form of sTLR-2 receptor immediately after the talc insufflation. This revealed low local reactivity to external stimuli. The effect of the treatment was not influenced by morphologic tumour type. No statistically significant differences in postoperative complications were found. This confirmed the safety of both videothoracoscopy and treatment. Conclusions. There was no correlation between the type of malignant affection and the outcome of the chemical pleurodesis. Patients with relapsing effusion have higher values of concentration of anti-inflammatory sCD-163 in pleural fluid even before the application of talc, and lower levels of concentration of inflammatory sTLR-2 immediately after application of talc.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [41] Talc pleurodesis for malignant pleural effusions is preferred over the pleurx catheter (Contrary position)
    Warren, William
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (10) : 2700 - 2701
  • [42] Talc Pleurodesis for Malignant Pleural Effusions Is Preferred Over the Pleurx Catheter (Contrary Position)
    William Warren
    Annals of Surgical Oncology, 2007, 14 : 2700 - 2701
  • [43] Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value
    Ukale, V
    Agrenius, V
    Widström, O
    Hassan, A
    Hillerdal, G
    RESPIRATORY MEDICINE, 2004, 98 (12) : 1166 - 1172
  • [44] Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in Japan
    Saka, Hideo
    Oki, Masahide
    Kitagawa, Chiyoe
    Kogure, Yoshihito
    Kojima, Yuki
    Saito, Akiko M.
    Ishida, Atsuko
    Miyazawa, Teruomi
    Takeda, Koji
    Nakagawa, Kazuhiko
    Sasada, Shinji
    Negoro, Shunichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (04) : 376 - 381
  • [45] Optimal therapy of malignant pleural effusions: Report of a randomized trial of bleomycin, tetracycline, and talc and a meta-analysis
    Lynch, TJ
    Kalish, L
    Mentzer, SJ
    Decamp, M
    Strauss, G
    Sugarbaker, DJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (01) : 183 - 190
  • [46] Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions
    Canto, A
    Guijarro, R
    Arnau, A
    Galbis, J
    Martorell, M
    Aguado, RG
    THORACIC AND CARDIOVASCULAR SURGEON, 1997, 45 (01) : 16 - 19
  • [47] Use of tunneled pleurae catheters for outpatient treatment of malignant Pleural effusions
    Stather, David Ryan
    Tremblay, Alain
    CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (04) : 328 - 333
  • [48] Utility of the combination of high fluorescence cells and tumor markers for the diagnosis of malignant pleural effusions
    Nuez-Zaragoza, Elisa
    Bhambi-Blanco, Indira
    Vidal-Pla, Monica
    Aparicio-Calvente, Isabel
    Escoda-Giralt, M. Rosa
    Gallardo-Campos, Joana
    Ferreres, Joan C.
    Frisancho, Luis
    Mas-Maresma, Laia
    Aguilera-Fernandez, Patricia
    Marco-Continente, Sonia
    Sierra-Boada, Marina
    Andreu-Cobo, Pablo
    Gallego, Miquel
    Trape, Jaume
    Aguadero, Vicente
    CLINICAL BIOCHEMISTRY, 2025, 136
  • [49] Treatment Options for Malignant Pleural Effusions Patient Preference Does Matter
    Maskell, Nick A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22): : 2432 - 2433
  • [50] Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions
    Akopov, AL
    Egorov, VI
    Varlamov, VV
    Levashev, YN
    Artioukh, DY
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (05) : 750 - 753